Find Out More

Antibody Innovation in Therapeutics


Monoclonal antibodies have reshaped modern medicine, and now a new wave of complex formats, like bispecifics and fragments, is driving the next revolution. These molecules offer exciting potential but also bring unique purification challenges. Their diverse structures often render standard monoclonal approaches ineffective, risking bioactive loss through aggregation and limiting the use of Fc binding for efficient purification.
 

Addressing Antibody Purification 


Ecolab produce a range of affinity resins for monoclonal antibody purification, with two showing specific properties that make them particularly successful in complex molecule purification: Praesto™ 70 CH1 and Praesto™ Jetted A50 HipH.

 

Praesto Jetted A50 HipH

Novel protein A based affinity resin for the first stage purification of monoclonal antibodies that are pH sensitive or prone to aggregation.

Find out more

Praesto 70 CH1

Novel affinity resin that selectively targets the CH1 domain of antibodies, rather than the Fc domain targeted by protein A based technologies

Find out more

Good caustic stability and cycle count

High capacity for greater process efficiency

Optimal flow properties

Available from lab to process scale

Read more

Case Study | Webinar

Overcoming Downstream Challenges in Next Generation Antibody Development

This joint webinar, presented by Bionova Scientific and Ecolab Life Sciences, explores practical strategies for addressing purification challenges in complex biologics. The session highlights the performance of Purolite™ Praesto™ Jetted A50 HipH resin, showcasing its ability to deliver high host cell protein clearance and support milder elution conditions - key advantages for downstream scientists working with monoclonal and bispecific antibodies.

Watch now
Application Note

Addressing Host Cell Protein Challenges in Monoclonal Antibody Production

This application note explores how Praesto Jetted A50 HipH resin can help address host cell protein (HCP) challenges in monoclonal antibody purification. It presents data showing up to 8.6× improvement in HCP removal compared to conventional protein A resins, achieved under milder elution conditions that may reduce aggregation risks. For scientists working to enhance product purity and process consistency, this note offers useful insights into optimizing resin performance.

Download
Whitepaper

Innovation and Evolution of Affinity Chromatography Resins for Antibody Purification

Affinity chromatography has become the gold standard for purifying monoclonal antibodies, transforming biomanufacturing capture steps. This whitepaper explores the evolution from early protein A ligands to today’s smart resins that respond to pH and temperature.

Download
CM eBook cover A
eBook

Complex Molecules eBook

Are you ready to revolutionize your approach to antibody purification? Discover the latest advancements in biopharmaceuticals with our exclusive eBook, Affinity Chromatography Resins for Complex Antibody Purification.

Download